Skip to main content
IMAGION BIOSYSTEMS LIMITED logo

IMAGION BIOSYSTEMS LIMITED — Investor Relations & Filings

Ticker · IBX ISIN · AU000000IBX6 ASX Professional, scientific and technical activities
Open in API
Filings indexed 659 across all filing types
Latest filing 2022-08-24 Interim / Quarterly Rep…
Country AU Australia
Listing ASX IBX

About IMAGION BIOSYSTEMS LIMITED

https://imagionbiosystems.com/

Imagion Biosystems Limited is a medical technology company specializing in the development of advanced diagnostic imaging solutions. The company's proprietary MagSense technology utilizes superparamagnetic iron oxide nanoparticles to detect specific cancer cells non-invasively. By functionalizing these nanoparticles with targeting antibodies, the system can identify the presence and location of malignancies, such as HER2-positive breast cancer, using highly sensitive magnetic sensors. This approach aims to provide a safer, more accurate alternative to traditional biopsy and imaging methods by eliminating the need for ionizing radiation or radioactive tracers. The technology is designed to improve clinical decision-making through earlier detection and better staging of diseases, ultimately enhancing patient outcomes in oncology.

Recent filings

Filing Released Lang Actions
Appendix 4D 3 pages 199.0KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'APPENDIX 4D FOR THE HALF-YEAR ENDED 30 JUNE 2022' and contains financial data for the half-year period ending June 30, 2022. It includes consolidated statements of profit and loss, financial position, cash flows, and changes in equity, which are typical components of an interim or quarterly financial report. The document length is 2840 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. The presence of detailed financial statements and notes references confirms it is a comprehensive interim report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-24 English
Half-Year Financial Report 18 pages 575.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Consolidated Half‐Year Financial Report - 30 June 2022' and includes a Directors' Report for the half-year ended 30 June 2022. It contains detailed financial information such as operating loss, revenue, expenses, research and development tax incentives, liquidity, and clinical development updates. The presence of comprehensive financial data and management discussion for a half-year period indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial statements and substantive financial analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-24 English
Half-Year Investor Presentation 29 pages 3.3MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation 25 August 2022' and contains detailed information about the company's technology, market opportunity, recent milestones, leadership, and product overview. It includes forward-looking statements, disclaimers, and is structured as a presentation aimed at investors. There are no financial statements or regulatory filings included, nor is it an announcement of a report publication. The content matches the definition of an Investor Presentation, which focuses on financials, strategy, and market position for investors.
2022-08-24 English
Half-Year Results Release 2 pages 122.4KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Imagion Biosystems 1H2022 Half-Year Results' and includes detailed financial and operational information for the half-year ended 30 June 2022. It contains financial figures such as cash balance, net loss, operating cash outflows, and discusses research and development costs and other expenses. The document is over 6,000 characters, indicating it is a substantive report rather than a brief announcement. The content aligns with a comprehensive interim or quarterly financial report, including financial statements and management commentary on business progress and outlook. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-24 English
Notification of cessation of securities - IBX 5 pages 25.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (securities) for IMAGION BIOSYSTEMS LIMITED. It provides specific information about the securities that have ceased, the reasons for cessation, and the updated issued capital following these changes. There is no indication of financial statements, management discussion, or other report content. The document is an announcement about changes in the company's issued securities, specifically the cessation of certain securities. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as cessation or lapse of securities.
2022-07-31 English
Application for quotation of securities - IBX 8 pages 29.9KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, and classifications under ASX rules. This is a formal announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about securities issuance and quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the actual announcement, not just a brief notice or report publication announcement.
2022-07-31 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.